<code id='D8EAA4010F'></code><style id='D8EAA4010F'></style>
    • <acronym id='D8EAA4010F'></acronym>
      <center id='D8EAA4010F'><center id='D8EAA4010F'><tfoot id='D8EAA4010F'></tfoot></center><abbr id='D8EAA4010F'><dir id='D8EAA4010F'><tfoot id='D8EAA4010F'></tfoot><noframes id='D8EAA4010F'>

    • <optgroup id='D8EAA4010F'><strike id='D8EAA4010F'><sup id='D8EAA4010F'></sup></strike><code id='D8EAA4010F'></code></optgroup>
        1. <b id='D8EAA4010F'><label id='D8EAA4010F'><select id='D8EAA4010F'><dt id='D8EAA4010F'><span id='D8EAA4010F'></span></dt></select></label></b><u id='D8EAA4010F'></u>
          <i id='D8EAA4010F'><strike id='D8EAA4010F'><tt id='D8EAA4010F'><pre id='D8EAA4010F'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:91291
          Senate health committee Chair Bernie Sanders
          Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

          Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

          advertisement

          But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Congress needs to close a vaccine
          Congress needs to close a vaccine

          VictorMoriyama/GettyImagesThePatientProtectionandAffordableCareAct,(generallyknownastheACA),wassigne

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Burning questions for the 2024 JPM Healthcare Conference

          AlexHogan/STATTheJ.P.MorganHealthcareConferenceisuponus,bringingitsfreneticmeetings,crowdedhallways,